Our Research, Medical and Innovation Department works to improve the UK environment for the research, development and manufacturing of medicines. The focus is also on promoting industry-academic-NHS collaboration and ensuring the UK is a leader in stratified medicines, early stage clinical studies and in the development of data on how medicines provide value to patients and the NHS (Real World Data).
In light of recent research which highlights the impact industry is having on scientific literature on the 3Rs (Replacement, Reduction and Refinement) principles of animal research, ABPI Policy Officer Nicola Platt considers the increased contribution and collaboration of industry towards reducing, refining and replacing animal testing in medicine development.Read more
The Government has today announced its commitment to launch the Early Access to Medicines Scheme (EAMS) in April. The journey towards this announcement started back in 2006 when the need to get medicines to patients faster, without compromising safety, was highlighted by Sir David Cooksey¹.Read more